Chronic shoulder pain is the second-most common orthopaedic complaint in the United States after knee pain^[@R1]^. Atraumatic rotator cuff tear is a frequent cause of shoulder pain and dysfunction in the population over 60 years of age and is present in up to 49.4% of patients with a history of shoulder complaints^[@R2]^. Symptomatic atraumatic rotator cuff tear is associated with functional limitation that can affect activities of daily living, sleep patterns, and overall quality of life^[@R3]-[@R5]^. Direct costs associated with surgical repair alone exceed \$1.5 billion annually in the United States^[@R4]-[@R7]^. The rate of surgery increased by 141% from 1996 to 2006 and continued to rise through 2012^[@R4],[@R5],[@R8]^.

While surgical repair has been shown to be effective, nonoperative approaches have recently demonstrated similar improvements^[@R6],[@R9]-[@R14]^. The American Academy of Orthopaedic Surgeons (AAOS) Appropriate Use Criteria (AUC) demonstrate the lack of guideline recommendations or consistent clinical opinion on the relative effectiveness and appropriateness of alternative treatment options for patients with atraumatic rotator cuff tear^[@R15]^. The AAOS physician panels agreed that repair was either appropriate or rarely appropriate for only 15% of 432 vignettes^[@R3]^.

Mixed expert opinion and limited clinical evidence on the effectiveness of alternative treatment paths for patients with an atraumatic rotator cuff tear create great potential for professional discretion in treating clinically similar patients. When evidence on treatment effectiveness is limited in health care, the costs associated with evidence diffusion^[@R16]-[@R20]^, variation in local area physician supply, specialty mix^[@R21]-[@R23]^, and market structures^[@R24]-[@R30]^ can lead to what have been termed as local *area treatment signatures*^[@R31]^, *practice styles*^[@R18],[@R32],[@R33]^, or *schools of thought*^[@R16],[@R34]^. The existence of area treatment signatures implies that the treatment provided to a patient will vary depending on where he or she lives and seeks care. The identification and measurement of area treatment signatures has been shown to be a vital first step for comparative effectiveness research of treatments in real-world practice^[@R35]-[@R41]^.

The treatment of atraumatic rotator cuff tears may be particularly susceptible to the formation of area treatment signatures resulting from a lack of clear and consistent evidence on the effectiveness of alternative treatment paths. However, to our knowledge, no studies have examined area treatment signatures for patients with atraumatic rotator cuff tears. The purposes of the present study were to examine factors influencing the initial treatment choice for patients with new symptomatic atraumatic rotator cuff tears and to assess the extent of area treatment signatures across hospital referral regions.

Materials and Methods {#s1}
=====================

The present study was a retrospective cohort study of Medicare beneficiaries with claims indicating a new magnetic resonance imaging (MRI)-confirmed atraumatic rotator cuff tear between January 2011 and March 2012. Complete Medicare claims and beneficiary summary files from 2010 to 2012 were obtained from the Chronic Conditions Data Warehouse^[@R42]^.

The initial cohort included 2,525,519 beneficiaries with any of 192 shoulder-related International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes in 2011. The index date for each beneficiary was defined as the date of the first shoulder-related diagnosis in 2011. To ensure data completeness, patients were excluded if they were not continuously enrolled in fee-for-service Medicare Parts A and B from 365 days before to 104 days after the index date, were \<66 years old at the index date, or had a residence ZIP code in 2011 that was outside the continental United States. Patients with any shoulder-related health-care utilization in the 365 days before the index date or who used either emergency department services or an ambulance transfer within 1 day before the index date were excluded in order to focus on new, nontraumatic problems.

A narrow definition for atraumatic rotator cuff tear was used to limit the extent of clinical variability among patients. Beneficiaries with an MRI-confirmed atraumatic rotator cuff tear were defined as those who had MRI of the upper-extremity within 90 days after the index date and a diagnosis of rotator cuff tear within 14 days after the earliest dated MRI^[@R43]^. Patients with complicating diagnoses, including cervical spine pain, scapular pain, glenohumeral arthritis, humeral fracture, inflammatory arthritis, adhesive capsulitis, or dementia during the period from 365 days before to 104 days after the index date were excluded, following published guidance^[@R6]^. Patients with any observed ICD-9 procedure code indicating anatomical shoulder replacement within 104 days after the index date were excluded. Table I details the sample exclusion process.

###### 

Medicare Cohort Size by Study Sample Inclusion Criteria[\*](#tblfn1){ref-type="table-fn"}

  Inclusion Criteria                                                                                                                                                                                                  No. of Patients
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------
  Medicare Part-B "carrier" claim with shoulder-related diagnosis in 2011 (index diagnosis)                                                                                                                           2,525,519
  No carrier claim with shoulder-related diagnosis in 365 days before index diagnosis in 2011                                                                                                                         1,871,294
  Continuously enrolled in Medicare Parts A and B, never enrolled in an HMO, from 365 days prior to index date to 104 days after index date                                                                           1,598,175
  Age of ≥66 years at index date                                                                                                                                                                                      1,588,184
  No claim indicating emergency department or ambulance use within 1 day before index date                                                                                                                            1,290,052
  Claim indicating MRI within 90 days after index date                                                                                                                                                                144,487
  Rotator cuff tear diagnosis within 14 days after first MRI                                                                                                                                                          65,220
  Complete data available for geography measures (hospital referral region, county-level statistics)                                                                                                                  63,075
  No cervical spine pain, scapular pain, glenohumeral arthritis, humeral fracture, inflammatory arthritis, adhesive capsulitis, or dementia during period 365 days prior to index date to 104 days after index date   32,203

HMO = health maintenance organization.

Initial Treatment Choice {#s1-1}
------------------------

Treatment was measured with use of ICD-9 procedure and Healthcare Common Procedure Coding System (HCPCS) codes on Medicare Part A and B claims over the 104-day post-index period. Patients were categorized into 1 of 2 primary treatment groups---surgery or physical therapy---on the basis of the first treatment received. Patients who did not receive surgery or physical therapy during the period were categorized into a third treatment group, watchful waiting. The table in the [Appendix](#app1){ref-type="sec"} provides complete definitions of treatment and all variables described below.

Patient Characteristics Affecting Treatment Choice {#s1-2}
--------------------------------------------------

Patient age; modified frailty index score^[@R44]^; use of a cane, walker, or wheelchair; Charlson comorbidity index score^[@R45],[@R46]^; and total Medicare payments made to providers over the 365 days prior to the index date were measured as patient-specific clinical factors. Health-care spending has been shown to be indicative of an individual's health status and health-care utilization characteristics^[@R47]^. Patient demographic characteristics, including sex, race, and Medicaid dual-eligibility status at the index date were also measured. The number of pre-index physical therapy visits that patients had in 2011 was measured to control for potential differences in out-of-pocket costs for therapy that arise through the cap placed on Medicare payments for therapy services by the Balanced Budget Act.

Independent relationships between patient characteristics and each treatment alternative were estimated with use of logistic regression models^[@R48]^. Continuous variables were cut and specified with use of binary variables for interpretability. Model-fit statistics included log-likelihood, McFadden R^2^, and Tjur R^2^ values^[@R49]-[@R51]^.

Area Treatment Signature Measurement {#s1-3}
------------------------------------

Area treatment signatures were measured at the hospital referral region level as the difference between the observed treatment rate and the expected treatment rate after adjusting for patient characteristics. Hospital referral regions are geographic regions developed by researchers with use of The Dartmouth Atlas of Heath Care^[@R52]^ to represent regional health-care markets for tertiary medical care; each hospital referral region includes at least 1 major hospital and a minimum population of 120,000^[@R22]^. Patients were assigned to a hospital referral region on the basis of residence ZIP code as documented in the 2011 Medicare Beneficiary Summary File.

Hospital referral region-specific *area treatment signatures* were estimated with use of an area treatment rate differential.

First, the observed treatment rates in each hospital referral region were calculated as the proportion of patients in the hospital referral region categorized as receiving surgery, physical therapy, and watchful waiting. Risk-adjusted treatment rates for each hospital referral region were then calculated as the average predicted probability of treatment, estimated with regression models as previously described, across patients in the hospital referral region^[@R40],[@R53]-[@R55]^. The area treatment rate differential for each hospital referral region was finally calculated by subtracting the observed rate from the expected rate for each treatment. The area treatment rate differential is therefore the difference between the unadjusted probability that patients in a hospital referral region received a given treatment, equal to the proportion of patients that received the treatment in that area, and the adjusted probability that the average patient in the full sample with the same characteristics received that treatment, estimated with use of regression models. Area treatment rate differentials represent the theorized collective influence of unmeasured factors specific to each local area that affect the initial treatment choice for an atraumatic rotator cuff tear. Ninety-five percent confidence intervals (CIs) around area treatment rate differentials were estimated with use of the bootstrap method (4,500 iterations)^[@R56],[@R57]^.

Area-Related Measures {#s1-4}
---------------------

Last, we assessed the extent that differences in the characteristics of physician access across hospital referral regions were correlated with variation in area treatment signatures. Physician access measures included 6 different measures of physician supply by specialty and 5 measures of physician specialty mix in 2011. The 6 supply measures included the total numbers of physicians, orthopaedic surgeons, physical therapists, primary care physicians, medical specialist physicians, and general surgeons per 100,000 residents in a hospital referral region. Measures of physician specialty mix were created for each specialty group as the ratio of specialty-specific physician supply to total physician supply. Data for hospital referral region-level physician supply were obtained from The Dartmouth Atlas of Health Care, which is funded by the Robert Wood Johnson Foundation and the Dartmouth Clinical and Translational Science Institute^[@R52]^. Correlations between the area treatment rate differential and the physician supply and specialty mix of the patient residence hospital referral region were evaluated with use of Pearson product-moment correlation, weighted by the number of patients in each hospital referral region.

Results {#s2}
=======

There were 32,203 patients with a new MRI-confirmed diagnosis of atraumatic rotator cuff tear in 2011 who met all inclusion criteria (Table I). The initial treatment was surgery for 19.8% of patients, physical therapy for 41.3%, and watchful waiting for 38.8%. Table II shows descriptive statistics for the cohort by treatment group. On average, patients who had initial surgery were younger, were more likely to be white and male, were less likely to be Medicare-Medicaid dual-eligible, and had fewer comorbid conditions than patients who received initial physical therapy or watchful waiting. Patients who received physical therapy were slightly younger and had greater comorbidity than patients who received watchful waiting.

###### 

Cohort Summary Characteristics

                                                                             All              Surgery          Physical Therapy   Watchful Waiting   P Value
  -------------------------------------------------------------------------- ---------------- ---------------- ------------------ ------------------ ---------
  No. of patients                                                            32,203 (100%)    6,388 (19.8%)    13,311 (41.3%)     12,504 (38.8%)     
  Treatment group *(no. of patients)*                                                                                                                \<0.001
   Surgery                                                                   6,388 (19.8%)    6,388 (100.0%)   0 (0.0%)           0 (0.0%)           
   Physical therapy                                                          13,311 (41.3%)   0 (0.0%)         13,311 (100.0%)    0 (0.0%)           
   Watchful waiting                                                          12,504 (38.8%)   0 (0.0%)         0 (0.0%)           12,504 (100.0%)    
  Age[\*](#tblfn2){ref-type="table-fn"} *(yr)*                               73.97 ± 5.80     72.52 ± 4.86     74.26 ± 5.82       74.39 ± 6.09       \<0.001
  Charlson comorbidity index[\*](#tblfn2){ref-type="table-fn"}               1.59 ± 1.97      1.29 ± 1.65      1.58 ± 1.95        1.75 ± 2.11        \<0.001
  Frailty index[\*](#tblfn2){ref-type="table-fn"}                            0.55 ± 0.81      0.45 ± 0.72      0.57 ± 0.81        0.59 ± 0.84        \<0.001
  Cane *(no. of patients)*                                                   168 (0.5%)       18 (0.3%)        74 (0.6%)          76 (0.6%)          0.014
  Walker *(no. of patients)*                                                 857 (2.7%)       123 (1.9%)       375 (2.8%)         359 (2.9%)         \<0.001
  Wheelchair *(no. of patients)*                                             284 (0.9%)       29 (0.5%)        102 (0.8%)         153 (1.2%)         \<0.001
  Prior physical therapy days[\*](#tblfn2){ref-type="table-fn"}              1.16 ± 4.50      0.69 ± 3.05      1.73 ± 5.67        0.79 ± 3.57        \<0.001
  Pre-365 Medicare reimbursements[\*](#tblfn2){ref-type="table-fn"} *(\$)*   7,601 ± 14,132   5,675 ± 9,495    7,977 ± 15,004     8,185 ± 15,043     \<0.001
  Male *(no. of patients)*                                                   16,175 (50.2%)   3,657 (57.2%)    6,136 (46.1%)      6,382 (51.0%)      \<0.001
  Race *(no. of patients)*                                                                                                                           \<0.001
   White                                                                     29,644 (92.1%)   6,018 (94.2%)    12,338 (92.7%)     11,288 (90.3%)     
   Black                                                                     1,389 (4.3%)     213 (3.3%)       500 (3.8%)         676 (5.4%)         
   Hispanic                                                                  401 (1.2%)       40 (0.6%)        143 (1.1%)         218 (1.7%)         
   Asian                                                                     264 (0.8%)       25 (0.4%)        126 (0.9%)         113 (0.9%)         
   Other                                                                     505 (1.6%)       92 (1.4%)        204 (1.5%)         209 (1.7%)         
  Medicaid dual-eligible *(no. of patients)*                                 2,204 (6.8%)     266 (4.2%)       719 (5.4%)         1,219 (9.7%)       \<0.001

The values are given as the mean and the standard deviation.

Assessing the Effects of Patient-Specific Characteristics on Treatment Choice {#s2-1}
-----------------------------------------------------------------------------

Odds-ratio estimates relating measured patient characteristics to each treatment alternative are shown in Table III. Increasing age and comorbidity were each associated with a lower probability of surgery and a higher probability of watchful waiting. Patients who were ≥86 years of age had an estimated 0.28-times (95% CI, 0.23 to 0.35) lower odds of receiving initial surgery, on average, than patients 66 to 69 years of age. Having a Charlson comorbidity index score of ≥4 was associated with a 0.73-times (95% CI, 0.66 to 0.82) lower odds of surgery and a 1.28-times (95% CI, 1.18 to 1.39) greater odds of watchful waiting relative to having a Charlson score of 0. On average, males had a 1.30-times (95% CI, 1.23 to 1.38) greater odds of surgery and a 0.76-times (95% CI, 0.73 to 0.80) lower odds of physical therapy as initial treatment. Non-white race and Medicaid dual eligibility were each associated with lower odds of surgery and higher odds of watchful waiting. Black females who were dual-eligible for Medicaid had a 0.42-times (95% CI, 0.34 to 0.50) lower odds of initial surgery and a 2.36-times (95% CI, 2.02 to 2.70) greater odds of watchful waiting relative to white, non-dual-eligible males.

###### 

Treatment Choice Logistic Regression Model Results

                                                        Surgery                                               Physical Therapy                                      Watchful Waiting
  ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- -----------------------------------------------------
  Model covariables[\*](#tblfn3){ref-type="table-fn"}                                                                                                               
   Clinical characteristics                                                                                                                                         
    Age group (ref: 66-69 yr)                                                                                                                                       
     70-75 yr                                           0.88 (0.82, 0.93)[†](#tblfn4){ref-type="table-fn"}    1.12 (1.06, 1.18)[†](#tblfn4){ref-type="table-fn"}    0.99 (0.93, 1.04)
     76-79 yr                                           0.66 (0.60, 0.72)[†](#tblfn4){ref-type="table-fn"}    1.20 (1.11, 1.28)[†](#tblfn4){ref-type="table-fn"}    1.11 (1.04, 1.19)[‡](#tblfn5){ref-type="table-fn"}
     80-85 yr                                           0.42 (0.38, 0.47)[†](#tblfn4){ref-type="table-fn"}    1.29 (1.20, 1.39)[†](#tblfn4){ref-type="table-fn"}    1.28 (1.19, 1.38)[†](#tblfn4){ref-type="table-fn"}
     ≥86 yr                                             0.28 (0.23, 0.35)[†](#tblfn4){ref-type="table-fn"}    1.19 (1.05, 1.35)[‡](#tblfn5){ref-type="table-fn"}    1.57 (1.39, 1.78)[†](#tblfn4){ref-type="table-fn"}
    Charlson comorbidity index (ref: 0)                                                                                                                             
     1                                                  0.94 (0.87, 1.01)[§](#tblfn6){ref-type="table-fn"}    0.94 (0.88, 1.00)[\#](#tblfn7){ref-type="table-fn"}   1.12 (1.05, 1.19)[†](#tblfn4){ref-type="table-fn"}
     2                                                  0.90 (0.82, 0.98)[\#](#tblfn7){ref-type="table-fn"}   1.00 (0.94, 1.08)                                     1.08 (1.00, 1.16)[\#](#tblfn7){ref-type="table-fn"}
     3                                                  0.85 (0.77, 0.95)[‡](#tblfn5){ref-type="table-fn"}    0.93 (0.85, 1.01)[§](#tblfn6){ref-type="table-fn"}    1.21 (1.11, 1.31)[†](#tblfn4){ref-type="table-fn"}
     ≥4                                                 0.73 (0.66, 0.82)[†](#tblfn4){ref-type="table-fn"}    0.94 (0.87, 1.02)                                     1.28 (1.18, 1.39)[†](#tblfn4){ref-type="table-fn"}
    Frailty index (ref: 0)                                                                                                                                          
     1                                                  0.96 (0.90, 1.03)                                     1.00 (0.94, 1.05)                                     1.03 (0.98, 1.09)
     2                                                  0.90 (0.80, 1.01)[§](#tblfn6){ref-type="table-fn"}    0.96 (0.87, 1.05)                                     1.12 (1.02, 1.22)[\#](#tblfn7){ref-type="table-fn"}
     ≥3                                                 0.78 (0.65, 0.94)[‡](#tblfn5){ref-type="table-fn"}    0.90 (0.79, 1.02)                                     1.25 (1.10, 1.42)[†](#tblfn4){ref-type="table-fn"}
    Cane                                                0.79 (0.47, 1.32)                                     0.92 (0.67, 1.26)                                     1.20 (0.88, 1.64)
    Walker                                              1.07 (0.87, 1.31)                                     0.91 (0.78, 1.06)                                     1.07 (0.92, 1.24)
    Wheelchair                                          0.76 (0.51, 1.12)                                     0.77 (0.60, 1.00)[\#](#tblfn7){ref-type="table-fn"}   1.42 (1.11, 1.82)[‡](#tblfn5){ref-type="table-fn"}
    Pre-365 Medicare reimbursements                                                                                                                                 
     \$1,400 to \$3,229                                 0.94 (0.87, 1.01)[§](#tblfn6){ref-type="table-fn"}    1.18 (1.10, 1.26)[†](#tblfn4){ref-type="table-fn"}    0.90 (0.84, 0.96)[‡](#tblfn5){ref-type="table-fn"}
     \$3,230 to \$7,369                                 0.85 (0.79, 0.93)[†](#tblfn4){ref-type="table-fn"}    1.28 (1.19, 1.37)[†](#tblfn4){ref-type="table-fn"}    0.88 (0.82, 0.94)[†](#tblfn4){ref-type="table-fn"}
     \$7,370 to \$621,000                               0.84 (0.76, 0.92)[†](#tblfn4){ref-type="table-fn"}    1.20 (1.11, 1.30)[†](#tblfn4){ref-type="table-fn"}    0.95 (0.87, 1.02)
    Prior physical therapy use (ref: 0)                                                                                                                             
     1-4 d                                              0.71 (0.60, 0.84)[†](#tblfn4){ref-type="table-fn"}    1.93 (1.72, 2.17)[†](#tblfn4){ref-type="table-fn"}    0.60 (0.52, 0.68)[†](#tblfn4){ref-type="table-fn"}
     5-9 d                                              0.74 (0.62, 0.88)[†](#tblfn4){ref-type="table-fn"}    1.85 (1.63, 2.10)[†](#tblfn4){ref-type="table-fn"}    0.61 (0.53, 0.70)[†](#tblfn4){ref-type="table-fn"}
     10-19 d                                            0.66 (0.55, 0.79)[†](#tblfn4){ref-type="table-fn"}    2.11 (1.86, 2.41)[†](#tblfn4){ref-type="table-fn"}    0.56 (0.48, 0.65)[†](#tblfn4){ref-type="table-fn"}
     ≥20 d                                              0.47 (0.34, 0.66)[†](#tblfn4){ref-type="table-fn"}    3.03 (2.48, 3.72)[†](#tblfn4){ref-type="table-fn"}    0.42 (0.34, 0.53)[†](#tblfn4){ref-type="table-fn"}
   Demographics                                                                                                                                                     
    Male                                                1.30 (1.23, 1.38)[†](#tblfn4){ref-type="table-fn"}    0.76 (0.73, 0.80)[†](#tblfn4){ref-type="table-fn"}    1.10 (1.05, 1.16)[†](#tblfn4){ref-type="table-fn"}
    Race (ref: white)                                                                                                                                               
     Black                                              0.78 (0.67, 0.91)[‡](#tblfn5){ref-type="table-fn"}    0.81 (0.73, 0.91)[†](#tblfn4){ref-type="table-fn"}    1.41 (1.26, 1.57)[†](#tblfn4){ref-type="table-fn"}
     Hispanic                                           0.61 (0.44, 0.87)[‡](#tblfn5){ref-type="table-fn"}    1.02 (0.82, 1.26)                                     1.23 (0.99, 1.52)[§](#tblfn6){ref-type="table-fn"}
     Asian                                              0.50 (0.33, 0.76)[‡](#tblfn5){ref-type="table-fn"}    1.51 (1.17, 1.94)[‡](#tblfn5){ref-type="table-fn"}    0.92 (0.72, 1.19)
     Other                                              0.87 (0.69, 1.10)                                     1.02 (0.85, 1.23)                                     1.08 (0.90, 1.30)
    Medicaid dual-eligible                              0.70 (0.61, 0.81)[†](#tblfn4){ref-type="table-fn"}    0.63 (0.57, 0.69)[†](#tblfn4){ref-type="table-fn"}    1.86 (1.69, 2.04)[†](#tblfn4){ref-type="table-fn"}
  Model summary and fit statistics                                                                                                                                  
   No. of patients                                      32,203                                                32,203                                                32,203
   Model R^2^                                                                                                                                                       
    McFadden                                            0.03                                                  0.02                                                  0.02
    Tjur                                                0.03                                                  0.03                                                  0.02
   Log likelihood                                                                                                                                                   
     Null                                               −16,041.27                                            −21,835.36                                            −21,510.82
     Model                                              −15,529.97                                            −21,389.15                                            −21,117.93
   Wald chi-square                                                                                                                                                  
     Clinical and demographic                           901.64                                                841.98                                                732.95
     Demographic                                        166.64                                                216.74                                                250.58
     Clinical                                           675.10                                                578.91                                                432.92

The values are given as the odds ratio, with the 95% CI in parentheses.

P \< 0.001.

P \< 0.01.

P \< 0.1.

P \< 0.05.

Geographic Variation in Treatment Rates {#s2-2}
---------------------------------------

The 304 hospital referral regions included, on average, 106 patients with an atraumatic rotator cuff tear. Across all hospital referral regions, the observed rates of surgery varied from 0% to 73%, the rates of physical therapy varied from 6% to 74%, and the rates of watchful waiting varied from 11% to 67%. There were 3 hospital referral regions (including 72 patients) in which no patient received surgery.

Area Treatment Signatures as Area Treatment Rate Differentials {#s2-3}
--------------------------------------------------------------

There was broad variation in the estimated area treatment rate differentials across hospital referral regions. Geographic variation in area treatment rate differentials is highlighted in Figure [1](#F1){ref-type="fig"}. Figure [1](#F1){ref-type="fig"}-A shows hospital referral regions categorized by the quintile of the area treatment rate differential for surgery. The average area treatment rate differential and the treatment rate across hospital referral regions in each quintile are provided in the figure key. Figure [1](#F1){ref-type="fig"}-B illustrates the surgery area treatment rate differential estimate and 95% CI for all hospital referral regions, from lowest to highest area treatment rate differential; a rug plot along the x axis shows relative sample size across hospital referral regions. Analogous plots for physical therapy and watchful waiting are provided in the [Appendix](#app1){ref-type="sec"}. Table IV provides quintile-level area treatment rate differential estimates and 95% CIs, as well as the mean and interquartile range of observed treatment rates, for all area treatment rate differential quintile groups.

![**Fig. 1-A** Hospital referral regions (HRRs) across the United States, colored by quintile of area treatment rate differential (ATRD) for surgery. A higher quintile reflects higher use of surgery in the hospital referral region than expected on the basis of average treatment patterns across the entire sample as estimated with use of logistic regression models. The range of values across hospital referral regions in each quintile is shown in the key at the bottom of the figure. **Fig. 1-B** Estimated ATRDs for surgery across HRRs, in ascending order. The vertical span of each point represents the 95% CI as estimated with the bootstrap method with 4,500 iterations. The color indicates the quintile of ATRD for surgery. The rug plot along the x axis (vertical black bars) shows the relative proportion of the sample that resides in each hospital referral region.](jbjsoa-3-e0005-g001){#F1}

###### 

Summary of Area Treatment Rate Differential Estimates and Observed Treatment Rates Across Quintiles of Treatment-Specific Area Treatment Rate Differentials

                                                                        Treatment-Specific Area Treatment Rate Differential Quintile                                                                    
  --------------------------------------------------------------------- -------------------------------------------------------------- --------------------- --------------------- -------------------- --------------------
  Surgery                                                                                                                                                                                               
   Area treatment rate differential[\*](#tblfn8){ref-type="table-fn"}   −0.10 (−0.21, 0.00)                                            −0.04 (−0.13, 0.06)   0.00 (−0.12, 0.13)    0.04 (−0.08, 0.16)   0.13 (−0.02, 0.43)
   Treatment rate[†](#tblfn9){ref-type="table-fn"}                      0.10 (0.08, 0.13)                                              0.16 (0.15, 0.17)     0.20 (0.19, 0.21)     0.24 (0.23, 0.25)    0.33 (0.29, 0.34)
  Physical therapy                                                                                                                                                                                      
   Area treatment rate differential[\*](#tblfn8){ref-type="table-fn"}   −0.16 (−0.37, −0.01)                                           −0.07 (−0.20, 0.06)   −0.01 (−0.13, 0.12)   0.05 (−0.08, 0.20)   0.14 (−0.01, 0.33)
   Treatment rate[†](#tblfn9){ref-type="table-fn"}                      0.24 (0.22, 0.29)                                              0.33 (0.32, 0.35)     0.40 (0.39, 0.42)     0.47 (0.45, 0.49)    0.56 (0.53, 0.59)
  Watchful waiting                                                                                                                                                                                      
   Area treatment rate differential[\*](#tblfn8){ref-type="table-fn"}   −0.11 (−0.28, 0.03)                                            −0.04 (−0.17, 0.09)   0.00 (−0.12, 0.11)    0.04 (−0.09, 0.18)   0.13 (−0.05, 0.34)
   Treatment rate[†](#tblfn9){ref-type="table-fn"}                      0.27 (0.24, 0.3)                                               0.35 (0.33, 0.36)     0.39 (0.37, 0.4)      0.43 (0.42, 0.44)    0.52 (0.48, 0.56)

The values are given as the mean, with the 95% CI in parentheses.

The values are given as the means, with the interquartile range in parentheses.

Across the 20% of hospital referral regions with the lowest area treatment rate differential for surgery (first quintile), the average area treatment rate differential was −0.10 and the average observed rate of surgery was 0.10. In other words, while only 10% of the patients in these hospital referral regions received initial surgery, it was expected that approximately 20% of patients in these hospital referral regions would have received surgery on the basis of their measured clinical and demographic characteristics. Put differently, about half as many patients living in those hospital referral regions received surgery as was expected on the basis of their measured characteristics. Conversely, patients living in hospital referral regions within the highest quintile of area treatment rate differential for surgery had an average area treatment rate differential of 0.13 and an observed surgery rate of 0.33, suggesting that while 33% of patients in the hospital referral region received surgery, only 20% were expected to receive surgery based on their measured characteristics (i.e., 62% more patients received surgery than expected). In other words, on average, patients in high-surgery areas appeared nearly twice as likely to receive surgery as the average patient with identical measured characteristics.

Associations Between Local-Area Provider Access and Area Treatment Signatures {#s2-4}
-----------------------------------------------------------------------------

Figure [2](#F2){ref-type="fig"} illustrates associations between alternative physician access measures and the area treatment rate differential for each treatment group. Separate plots are drawn for each treatment-access measure combination. Each plot shows the LOESS fit relating the hospital referral region's area treatment rate differential value ranking (x axis) to the hospital referral region's physician access measure (y axis; measured as the percent difference from the mean). The Pearson correlation coefficient and p value testing the association are noted in each plot. The terms *Supply* and *Proportion* that appear in the right margin of the figure denote per-capita physician supply and specialty-mix measures, respectively.

![Associations between alternative physician access measures and treatment-specific area treatment rate differentials (ATRDs) at the hospital referral region (HRR) level. Separate plots were drawn for each treatment and access measure combination. Trend lines, drawn with use of the LOESS local regression method, show the bivariate relationship between area treatment rate differential value ranking of HRRs in ascending order (x axis) and the HRR physician access measure (as the percent difference from the mean) (y axis). Mean difference was calculated by subtracting the mean value of the access measure across HRRs from each HRR's specific access measure value. The values at the upper left corner of each plot represent the Pearson correlation coefficient and p value testing the association between the ATRD and the access measure values across HRRs, weighted by HRR sample size. Data pertaining to per-capita physician supply are represented by "Supply" and are shown in black. Data pertaining to the proportion of all physicians in a given specialty are represented by "Proportion" and are shown in red. PT = physical therapy.](jbjsoa-3-e0005-g002){#F2}

Greater local-area physician supply was associated with greater use of initial physical therapy and lower use of surgery or watchful waiting (p \< 0.01 for all). A greater proportion of providers in an area who were orthopaedic surgeons was associated with a higher surgery area treatment rate differential, whereas greater access to physical therapists was associated with a greater physical therapy area treatment rate differential and a lower surgery area treatment rate differential (p \< 0.01 for all).

Discussion {#s3}
==========

The present study demonstrated wide variation in the initial treatment of elderly patients with atraumatic rotator cuff tears, consistent with established literature documenting unwarranted variation in the treatment of patients with orthopaedic problems^[@R58]-[@R62]^. This study contributes to our understanding of initial treatment utilization for elderly patients with an atraumatic rotator cuff tear, the influence of patient characteristics on these decisions, the presence of area treatment signatures in this context, and how area treatment signatures are correlated with physician supply and specialty mix across areas.

Measured clinical and demographic characteristics had significant independent relationships with initial treatment choice but together accounted for only 2% to 3% of observed variation. Although R^2^ statistics in models with binary dependent variables should be interpreted with caution, the high degree of unexplained variation in treatment choice supports the idea that treatment may be highly sensitive to nonclinical factors or, perhaps more interestingly, that there is inconsistency across providers in terms of their beliefs about the appropriateness and effectiveness of alternative treatment paths for clinically identical patients. Patients with an atraumatic rotator cuff tear and other musculoskeletal problems often may face trade-offs across alternative domains of outcomes when deciding on a treatment course. For example, the optimum treatment may differ for clinically identical patients who diverge in terms of their goals related to improvements in pain and range of motion.

Physician supply and specialty mix in the hospital referral region where patients lived were correlated with area treatment signatures in the present study. Generally, patients were observed to be more likely to use treatments to which they had greater access. Patients in areas in which a greater proportion of physicians were orthopaedic surgeons were more likely to have initial surgery, whereas those in areas with greater access to physical therapists were more likely to receive physical therapy. These results lend support to the idea that the initial treatment for an atraumatic rotator cuff tear is sensitive to the characteristics of the region and health-care system where a patient presents and that these factors contribute to the presence of area treatment signatures. However, these correlations should not be interpreted causally. It is possible, for example, that an area's rurality or other socioeconomic characteristics are associated with physician access and treatment choice. Furthermore, interpretation may be complicated from correlation or interactions between supplies of different specialty groups and by the reciprocal relationship between supply and demand. Additional research is necessary to more accurately estimate the influence of individual contributors to seemingly unwarranted variation in treatment.

Several limitations related to the use of administrative data must be considered when interpreting the results of the present study. Administrative data reflect utilization only and may not reflect provider recommendation or intent. Identifying patients with an atraumatic rotator cuff tear using ICD-9 codes is also unvalidated and may suffer from poor sensitivity or specificity, particularly for patients who are managed nonoperatively. The present study applied stringent inclusion criteria in order to maximize confidence that the cohort was consistent with those of prior studies that have suggested that a treatment paradigm does, or should, exist^[@R4],[@R6],[@R9],[@R15]^. Administrative data also lack information on specific clinical characteristics that may influence treatment decisions in practice, such as a patient's clinical presentation (e.g., tear size, fatty infiltration, muscle atrophy, pain level, and range of motion)^[@R3]^. Age and comorbidity may capture some of the variation in these anatomical factors. Importantly, we are aware of no evidence to suggest that unmeasured clinical characteristics vary systematically across hospital referral regions, and risk of bias from unmeasured clinical characteristics is therefore thought to be minimal. Despite their inherent limitations, observational data are necessary for studying the determinants of treatment choices, and the implications of those choices, in the real world.

In conclusion, rates of alternative initial treatments used by patients with atraumatic rotator cuff tears varied widely across the United States after controlling for clinical and demographic characteristics. Associations between these risk-adjusted rates and area-level provider-supply measures support the idea that treatment signatures exist. The implications of this variation on the broad array of clinical and cost-related outcomes potentially affected by early treatment choices for atraumatic rotator cuff tears are unknown. A natural next step is to ask (1) whether specific treatments are overused or underused and (2) whether treatment rates could be modified to improve patient outcomes or lower costs. Under certain assumptions, treatment variation of the nature found in the present study can be used to address these questions. Research on the determinants of treatment choice for atraumatic rotator cuff tears is necessary in order to contextualize and ascertain the validity of those assumptions, ultimately facilitating the conduct and interpretation of research assessing the potential impacts of efforts to modify treatment practice.

Appendix {#app1}
========

Supplementary materials including (1) a table showing full descriptions of the study concepts and variables and (2) figures showing ATRD (area treatment rate differential) plots for physical therapy and watchful waiting are available with the online version of this article as a data supplement at [jbjs.org](http://jbjs.org) (<http://links.lww.com/JBJSOA/A57>).
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